Optimizing the medical management of acute coronary syndromes

被引:8
作者
Cannon, CP [1 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc,Dept Med, Boston, MA 02115 USA
关键词
D O I
10.1023/A:1008841721975
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:171 / 189
页数:19
相关论文
共 146 条
[121]   AN INTERNATIONAL RANDOMIZED TRIAL COMPARING 4 THROMBOLYTIC STRATEGIES FOR ACUTE MYOCARDIAL-INFARCTION [J].
TOPOL, E ;
CALIFF, R ;
VANDEWERF, F ;
ARMSTRONG, PW ;
AYLWARD, P ;
BARBASH, G ;
BATES, E ;
BETRIU, A ;
BOISSEL, JP ;
CHESEBRO, J ;
COL, J ;
DEBONO, D ;
GORE, J ;
GUERCI, A ;
HAMPTON, J ;
HIRSH, J ;
HOLMES, D ;
HORGAN, J ;
KLEIMAN, N ;
MARDER, V ;
MORRIS, D ;
OHMAN, M ;
PFISTERER, M ;
ROSS, A ;
RUTSCH, W ;
SADOWSKI, Z ;
SIMOONS, M ;
VAHANIAN, A ;
WEAVER, WD ;
WHITE, H ;
WILCOX, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (10) :673-682
[122]  
Topol E, 1998, NEW ENGL J MED, V339, P436
[123]   A RANDOMIZED CONTROLLED TRIAL OF INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR AND EARLY INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION [J].
TOPOL, EJ ;
GEORGE, BS ;
KEREIAKES, DJ ;
STUMP, DC ;
CANDELA, RJ ;
ABBOTTSMITH, CW ;
ARONSON, L ;
PICKEL, A ;
BOSWICK, JM ;
LEE, KL ;
ELLIS, SG ;
CALIFF, RM .
CIRCULATION, 1989, 79 (02) :281-286
[124]   SCORECARD CARDIOVASCULAR MEDICINE - ITS IMPACT AND FUTURE-DIRECTIONS [J].
TOPOL, EJ ;
CALIFF, RM .
ANNALS OF INTERNAL MEDICINE, 1994, 120 (01) :65-70
[125]   Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta(3) blockade with percutaneous coronary intervention [J].
Topol, EJ ;
Ferguson, JJ ;
Weisman, HF ;
Tcheng, JE ;
Ellis, SG ;
Kleiman, NS ;
Ivanhoe, RJ ;
Wang, AL ;
Miller, DP ;
Anderson, KM ;
Califf, RM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (06) :479-484
[126]   READINESS FOR THE SCORECARD ERA IN CARDIOVASCULAR MEDICINE [J].
TOPOL, EJ ;
BLOCK, PC ;
HOLMES, DR ;
KLINKE, WP ;
BRINKER, JA .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (16) :1170-1173
[127]   RANDOMIZED TRIAL OF CORONARY INTERVENTION WITH ANTIBODY AGAINST PLATELET IIB/IIIA INTEGRIN FOR REDUCTION OF CLINICAL RESTENOSIS - RESULTS AT 6 MONTHS [J].
TOPOL, EJ ;
CALIFF, RM ;
WEISMAN, HF ;
ELLIS, SG ;
TCHENG, JE ;
WORLEY, S ;
IVANHOE, R ;
GEORGE, BS ;
FINTEL, D ;
WESTON, M ;
SIGMON, K ;
ANDERSON, KM ;
LEE, KL ;
WILLERSON, JT ;
SMITH, CR ;
WEISMAN, H .
LANCET, 1994, 343 (8902) :881-886
[128]  
Topol EJ, 1997, NEW ENGL J MED, V336, P1689
[129]  
Topol EJ, 1996, NEW ENGL J MED, V335, P775
[130]  
TOPOL EJ, 1994, NEW ENGL J MED, V331, P1323